More about parkinsonism after taking ecstasy.
Baggott
M
M
Mendelson
J
J
Jones
R
R
D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D013997:Time Factors
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine